Do you want to be part of the largest gathering of mRNA professionals?
The 2nd Annual mRNA-Based Therapeutics Summit is returning in-person to Boston this July 26-28.
Expect exclusive data from the movers and shakers in mRNA vaccine and therapy development, 75+ world-class speakers, 5 dedicated tracks of content, and 45+ deep-dive case studies. Learn more here: https://ter.li/dicvhy
Here’s a snapshot of the expert speakers you can hear from:
- Kathy Fernando, VP, Head of Worldwide Research, Development and Medical Operations & Head of mRNA Scientific Planning, Pfizer
- Regis Gervier, Global Head, mRNA Center of Excellence, Sanofi
- Rituparna Das, VP – COVID Vaccines, Moderna
- Hao Chen, Global Head of Cell & Viral Drug Substance, GlaxoSmithKline
- Joe Payne, Founder, President & CEO, Arcturus Therapeutics
- Pervin Anklesaria, Deputy Director, HIV Vaccines & Biologics, Bill & Melinda Gates Foundation
- Manmohan Singh, SVP – Pharmaceutical Sciences & Delivery Technologies, Beam Therapeutics
- Akhilesh Bhambhani, Senior Director – Biologics Drug Product Development; Tech Dev/Tech Ops, Ultragenyx
- Liang Shang, Senior Scientist – Vaccine Analytical, Merck
- Russell Johnson, VP – Formulation Research, RVAC Medicines
- Tamar Grossman, Global Head – RNA & Targeted Therapeutics, The Janssen Pharmaceutical Companies of Johnson & Johnson
Download the official brochure to discover why Sanofi, Ultragenyx, Beam Therapeutics, Pfizer, Moderna, Merck, Eli Lilly, GSK, and many others have already secured their places. https://ter.li/dicvhy
The post 2nd Annual mRNA-Based Therapeutics Summit appeared first on .
